Maria-Luisa Maccecchini - 03 Jan 2022 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Jeffrey McGroarty, Attorney-in-Fact for Maria L. Maccecchini
Issuer symbol
ANVS
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
05 Jan 2022, 18:42:22 UTC
Previous filing
18 Jan 2022
Next filing
18 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +83,400 $0.000000 83,400 03 Jan 2022 Common Stock 83,400 $19.78 Direct F1
transaction ANVS Stock Option (right to buy) Award $0 +19,894 $0.000000 19,894 03 Jan 2022 Common Stock 19,894 $19.78 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest in eight consecutive quarterly installments of 10,425 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024.
F2 The stock option shall vest and become exercisable in two equal installments of 9,947 shares on March 31, 2022 and March 31, 2023.